119 related articles for article (PubMed ID: 3283488)
1. Characterization and possible opioid modulation of N-methyl-D-aspartic acid induced increases in serum luteinizing hormone levels in the developing male rat.
Cicero TJ; Meyer ER; Bell RD
Life Sci; 1988; 42(18):1725-32. PubMed ID: 3283488
[TBL] [Abstract][Full Text] [Related]
2. Luteinizing hormone releasing hormone mediates naloxone's effects on serum luteinizing hormone levels in normal and morphine-sensitized male rats.
Cicero TJ; Schmoeker PF; Meyer ER; Miller BT
Life Sci; 1985 Aug; 37(5):467-74. PubMed ID: 3894852
[TBL] [Abstract][Full Text] [Related]
3. The N-methyl-D-aspartate-mediated inhibitory control of gonadotropin-releasing hormone release in the hypothalamus of the adult male guinea pig is expressed through opioidergic systems.
Giri M; Gao C; Kaufman JM
Endocrinology; 1996 Apr; 137(4):1468-73. PubMed ID: 8625925
[TBL] [Abstract][Full Text] [Related]
4. Mechanisms of altered LH secretion in neonatally oestrogenized male rats.
Pinilla L; Tena-Sempere M; Gonzalez D; Aguilar E
J Endocrinol; 1995 Oct; 147(1):43-50. PubMed ID: 7490535
[TBL] [Abstract][Full Text] [Related]
5. Glutamate receptors of the non-N-methyl-D-aspartic acid type mediate the increase in luteinizing hormone-releasing hormone release by excitatory amino acids in vitro.
Donoso AO; López FJ; Negro-Vilar A
Endocrinology; 1990 Jan; 126(1):414-20. PubMed ID: 2152870
[TBL] [Abstract][Full Text] [Related]
6. Occurrence of D-aspartic acid and N-methyl-D-aspartic acid in rat neuroendocrine tissues and their role in the modulation of luteinizing hormone and growth hormone release.
D'Aniello A; Di Fiore MM; Fisher GH; Milone A; Seleni A; D'Aniello S; Perna AF; Ingrosso D
FASEB J; 2000 Apr; 14(5):699-714. PubMed ID: 10744627
[TBL] [Abstract][Full Text] [Related]
7. Differential effects of the N-methyl-D-aspartate and non-N-methyl-D-aspartate receptors of the excitatory amino acids system on LH and FSH secretion. Its effects on the hypothalamic luteinizing hormone releasing hormone during maturation in male rats.
Carbone S; Szwarcfarb B; Rondina D; Feleder C; Moguilevsky JA
Brain Res; 1996 Jan; 707(2):139-45. PubMed ID: 8919290
[TBL] [Abstract][Full Text] [Related]
8. Endogenous opioid peptides mediate the interleukin-1-induced inhibition of the release of luteinizing hormone (LH)-releasing hormone and LH.
Kalra PS; Fuentes M; Sahu A; Kalra SP
Endocrinology; 1990 Nov; 127(5):2381-6. PubMed ID: 2226323
[TBL] [Abstract][Full Text] [Related]
9. Ontogeny of the opioid-mediated control of reproductive endocrinology in the male and female rat.
Cicero TJ; Schmoeker PF; Meyer ER; Miller BT; Bell RD; Cytron SM; Brown CC
J Pharmacol Exp Ther; 1986 Mar; 236(3):627-33. PubMed ID: 3512817
[TBL] [Abstract][Full Text] [Related]
10. Hypothalamic site of action for N-methyl-D-aspartate (NMDA) on LH secretion.
Ondo JG; Wheeler DD; Dom RM
Life Sci; 1988; 43(26):2283-6. PubMed ID: 3062296
[TBL] [Abstract][Full Text] [Related]
11. Exogenous and endogenous opioid-induced enhancements of naloxone's effects on serum luteinizing hormone levels in the male rat.
Cicero TJ; Owens DP; Newman KS; Schmoeker PF; Meyer ER
Eur J Pharmacol; 1984 Oct; 105(3-4):273-84. PubMed ID: 6096156
[TBL] [Abstract][Full Text] [Related]
12. Endogenous opioid peptide regulation of pulsatile luteinizing hormone secretion during pregnancy in the rat.
Devorshak-Harvey E; Bona-Gallo A; Gallo RV
Neuroendocrinology; 1987 Nov; 46(5):369-78. PubMed ID: 3323939
[TBL] [Abstract][Full Text] [Related]
13. Direct activation of gonadotropin-releasing hormone secretion through different receptors to neuroexcitatory amino acids.
Bourguignon JP; Gérard A; Franchimont P
Neuroendocrinology; 1989 Apr; 49(4):402-8. PubMed ID: 2541362
[TBL] [Abstract][Full Text] [Related]
14. Opioidergic modulation of N-methyl-D,L-aspartic-acid-stimulated LH release in young adult but not older male mice.
Miller GM; Gibson MJ
Neuroendocrinology; 1994 Mar; 59(3):277-84. PubMed ID: 8159277
[TBL] [Abstract][Full Text] [Related]
15. Age-related differences in the sensitivity of serum luteinizing hormone to prototypic mu, kappa and delta opiate agonists and antagonists.
Cicero TJ; Meyer ER; Miller BT; Bell RD
J Pharmacol Exp Ther; 1988 Jul; 246(1):14-20. PubMed ID: 2839658
[TBL] [Abstract][Full Text] [Related]
16. Antagonist of gonadotropin-releasing hormone blocks naloxone-induced elevations in serum luteinizing hormone.
Blank MS; Roberts DL
Neuroendocrinology; 1982 Nov; 35(5):309-12. PubMed ID: 6755289
[TBL] [Abstract][Full Text] [Related]
17. Intraventricular injection of melatonin inhibits naloxone-induced, but not NMDA- or LHRH-induced LH release in ovariectomized estrogen-primed rats.
Akema T; Ikeda T; Chiba A; Sugiyama H; Sato I; Kimura F; Toyoda J
Endocr J; 1999 Dec; 46(6):831-6. PubMed ID: 10724360
[TBL] [Abstract][Full Text] [Related]
18. Endogenous opioids participate in the regulation of the hypothalamus-pituitary-luteinizing hormone axis and testosterone's negative feedback control of luteinizing hormone.
Cicero TJ; Schainker BA; Meyer ER
Endocrinology; 1979 May; 104(5):1286-91. PubMed ID: 374068
[TBL] [Abstract][Full Text] [Related]
19. Ethanol inhibits the naloxone-induced release of luteinizing hormone-releasing hormone from the hypothalamus of the male rat.
Cicero TJ; Newman KS; Gerrity M; Schmoeker PF; Bell RD
Life Sci; 1982 Oct; 31(15):1587-96. PubMed ID: 6755122
[TBL] [Abstract][Full Text] [Related]
20. Effects of ovarian steroids on the gonadotropin response to N-methyl-D-aspartate and on hypothalamic excitatory amino acid levels during sexual maturation in female rats.
Carbone S; Szwarcfarb B; Otero Losada ME; Moguilevsky JA
Endocrinology; 1992 Mar; 130(3):1365-70. PubMed ID: 1347007
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
